First in Europe: EUR 100 million of equity finance for Belgian SMEs under the EIF-NPI Fund Underwriting Programme

  •   Release date: 14 February 2019
The European Investment Fund (EIF) and the Belgian Federal Holding and Investment Company (SFPI-FPIM) have signed the first agreement in Europe under the EIF-NPI Fund Underwriting Programme.
 

EIF supported INVL Baltic Sea Growth Fund holds first closing at EUR 106 million

  •   Release date: 08 February 2019
EIF supported INVL Asset Management, one of Lithuania’s leading asset management companies, completed a first closing of the INVL Baltic Sea Growth Fund, a closed-end private equity fund at EUR 106 million. The INVL Baltic Sea Growth Fund became the largest private equity investment fund in the Baltic countries.
 

EU bank steps up efforts to fight climate change and foster innovation

  •   Release date: 29 January 2019
In the year of its 60th anniversary, the EU bank supported EUR 230 billion of investment, meeting its Juncker Plan targets ahead of schedule and successfully navigating a politically difficult environment. Shifting its focus from Europe’s economic recovery to competitiveness, the European Investment Bank (EIB) Group zoomed in on market gaps identified by its experts, so that its investments would have the biggest impact on Europe’s economy. “Digitalisation, SMEs, education ...
 

Investment Plan: EIF and HBOR launch new equity investment programme in Croatia for SMEs and midcaps

  •   Release date: 28 January 2019
The European Investment Fund (EIF) and HBOR are launching (CROGIP), a EUR 70 million-investment programme to support fast-growing SMEs and mid-caps established and operating in Croatia. The investment programme is supported by the European Fund for Strategic Investments (EFSI), the core of the Investment Plan for Europe.
 

Vesalius Biocapital III Announces Significant Investment from the European Investment Fund

  •   Release date: 17 January 2019
Vesalius Biocapital III, the specialist life sciences venture capital investor, announces an investment of €30 million by the European Investment Fund (EIF). This secures commitments of €110 million to date. Until the final closing, scheduled for end April 2019, Vesalius Biocapital III will accept new investors on a “rolling closing” basis. The fund will invest in later-stage European life sciences companies, providing capital to support their development. Vesalius ...
 
 

We use cookies to give the best browser experience on our website. or change cookie settings.


 
 

Copyright ©

 European Investment Fund 2019 – The European Investment Fund is not responsible for the content of external internet sites.